August 22, 2017

FDA Approves Bipolar Radiofrequency Surgical Ablation System for Persistent Atrial Fibrillation

The Food and Drug Administration (FDA) approved the AtriCure Synergy Ablation System for the treatment of persistent and longstanding persistent atrial fibrillation in patients undergoing another heart surgery. The Synergy bipolar radiofrequency clamp is the only surgical ablation device with FDA approval for afib treatment.

Learn more: FDA Advisory Panel Recommends, and FDA Approves, Bipolar Radiofrequency Clamp for Concomitant Surgery for Persistent Atrial Fibrillation

Comment